The global omega-3 finished product market was worth €28 billion in 2015 and is set for pan-sector growth in the coming years to add €5bn by 2018, despite sustainability and scientific challenges.
An approved EFSA claims that omega-3 form DHA contributes to the visual development of infants risks misleading consumers, due to a committee oversight in approving the relevant health claim, says UK-based breast-feeding advocacy group Baby Milk Action.